Mexico Govt pays USD 160 million to WHO to access COVAX vaccine plan

The latest payment will allow Mexico to acquire enough doses of a vaccine to immunise up to a fifth of the country's population of around 125 million people, the foreign ministry said.

Published On 2020-10-12 05:15 GMT   |   Update On 2020-10-12 08:18 GMT

Mexico: Mexico's government announced that it paid the World Health Organization $159.88 million to secure access to COVID-19 vaccines through the agency's COVAX plan as countries across the globe race to secure supplies.

The global health agency's COVAX Facility is a multilateral initiative running trials on several potential vaccines. The latest payment will allow Mexico to acquire enough doses of a vaccine to immunise up to a fifth of the country's population of around 125 million people, the foreign ministry said.

The foreign ministry statement added that the government had presented the "risk guarantee" paperwork for another $20.6 million, which it described as part of the contractually required commitments to access the eventual vaccine supply. The statement did not provide additional details on the second payment.

Read also: Bharat Biotech Covaxin to use ViroVax adjuvant for long-term immunity

According to the health ministry, Mexico has confirmed nearly 810,000 cases of the highly-contagious respiratory disease caused by the coronavirus, along with more than 83,000 recorded deaths, though both likely represent only a fraction of the true number of infections and fatalities due to little testing.

The government signed its COVAX contract late last month.

Read also: China signs deal to ensure COVID vaccines to developing countries



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News